The global lactulose market comprises products that contain lactulose, a disaccharide, which is commonly used as a carbohydrate source for gut microbiota. Lactulose is produced through the isomerization of lactose and is used for medical purposes including treatment of constipation and hepatic encephalopathy. It works as a prebiotic by stimulating the growth of beneficial gut bacteria such as Bifidobacterium and Lactobacillus in the large intestine. Lactulose products are available in various forms including solutions, tablets, and capsules and are prescribed by physicians for efficient treatment.
The global lactulose market is estimated to be valued at US$ 175.29 Mn in 2023 and is expected to exhibit a CAGR of 3.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
Lactulose acts as a prebiotic and stimulates growth of beneficial gut bacteria. This property has augmented its usage in food and beverage applications for enhancing digestive health. The rising awareness about gut health and related issues among consumers is fueling the demand for prebiotic-rich foods and supplements containing lactulose.
Treatment of constipation and hepatic encephalopathy: Lactulose is predominantly used for medical applications in treatment of constipation and hepatic encephalopathy. It works by drawing water into the colon to soften the stool and ease bowel movement. In hepatic encephalopathy, it helps remove excessive ammonia from the blood through diarrhea. The growing prevalence of these medical conditions drives the uptake of lactulose products globally.
Segment Analysis
The global lactulose market is dominated by the liquid sub-segment with a market share of over 70% in 2023. Lactulose in liquid form is easier for consumption and absorption in the body compared to tablets or capsules. The liquid form provides quick relief and prevents constipation. It is also suitable for aged people and children who find it difficult to swallow large tablets or capsules. This makes liquid lactulose highly preferred among consumers and doctors for treatment of constipation, hepatic encephalopathy, and other gastro-intestinal disorders.
PEST Analysis
Political: The government regulations regarding food additives and medicines are encouraging the growth of the lactulose market. Many countries have approved the usage of lactulose as a pharmaceutical product.
Economic: The rising disposable incomes and growing health awareness among the middle-class population are increasing the demand for lactulose products. The rise in cases of constipation related problems and liver diseases is also fueling the market growth.
Social: Changing lifestyles, hectic work schedules, junk food consumption are leading to increased cases of constipation globally. The non-habitual toilet habits along with rising geriatric population are augmenting the social demand for lactulose.
Technological: Manufacturers are focusing on innovative production technologies to improve the taste and dissolve time of lactulose products. Some players are utilizing advanced packaging solutions for enhancing product quality and safety.
Key Takeaways
The Global Lactulose Market Demand is expected to witness high growth over the forecast period of 2023 to 2030. Regionally, North America captured over 35% share of the global market in 2023 and is expected to maintain dominance due to rising healthcare expenditure and growing digestive issues in the region. Europe followed North America with over 25% share and is projected to witness considerable expansion owing to supportive government initiatives for research.
Key players operating in the lactulose market are Abbott, Morinaga Milk Industry CO., LTD., RELAX EXCELLENCE IN LACTULOSE, FRESENIUS KABI, BIOFAC A/S and Lactose India Limited. Abbott led the global market with a share of around 15% in 2023 on the back of its extensive distribution network and wide product portfolio. The company focuses on expanding its lactulose syrup and tablet offerings through strategic collaborations.
Morinaga Milk Industry CO., LTD specialized in the production and sale of lactulose and ranked among the top players globally. It has a strong presence across Japan and other Asian countries. The company’s lactulose as a pharmaceutical product has received approvals from regulatory authorities like the US Food and Drug Administration (FDA).
Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it